Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (501)	5/4/1998 11:41:00 AM
From: jjs_ynot	Read Replies (1) \| Respond to of 2135

Is it true that ENMD is working under contract for Bristol Meyers and that BMY owns any rights to any drug developed?

To: StockDoc who wrote (501)	5/4/1998 11:45:00 AM
From: Haolin Ni	Respond to of 2135

< it should be above 100 next year.> You must be mad. Tell us which drug company price increased 10 fold in one year? Where is the earning? Do you know each drug against cancel for humans need several to do a clinical trial?

To: StockDoc who wrote (501)	5/4/1998 12:16:00 PM
From: Cosmo Daisey	Read Replies (2) \| Respond to of 2135

Stock Doc, """If the drug works in man as preliminary clinical data now suggest (it's coming, watch out), and they can manufacture, it should be above 100 next year. StockDoc""" If it works try over $5000 next year. CD

To: StockDoc who wrote (501)	5/4/1998 8:20:00 PM
From: dougjn	Read Replies (1) \| Respond to of 2135

StockDoc, how do you get your $100 figure? Firstly, I am well aware of the possibility that though the combination works extremely well in mice, it may not in humans. But it looks unusually promising to me. Lets leave all that aside. Say it does work. As well in people as in mice. It will then clearly be one of medicine's most outstanding achievementsof all time. All kudos. Incredible human advance. But to return to money grubbing. <g> I can imagine that although far more important than Viagra, e.g., it might do far less well as a drug. 1) Far fewer people at any one moment in time probably suffer from cancer than from some sort of ED. Especially when you add in those who feel things could be improved in the erection department.<g> 2) At least in mice, these wonder drugs appear to not take very long to be completely effective. And then don't require further administration. And of course Enmd will have to farm out a lot or all of the actual manufacturing (even if its patent rights are unassailable and cannot be readily substituted around). On the other hand, even at today's close Enmd is still a relatively small cap. company. Have you seen or done any sort of projection of what the profits might be when and if sales began? (I was sniffing around here last night, but stayed well clear of this stock when it opened at what 80 or something. I knew it would fall back, and suspect it will fall a lot further from here in a little while.) Doug